Biological Mechanisms of Action of Novel C-10 Non-Acetal Trioxane Dimers in Prostate Cancer Cell Lines

The mechanisms of action of three C-10 non-acetal trioxane dimers (TDs) were examined in human (LNCaP) and mouse (TRAMP-C1A and -C2H) prostate cancer cell lines. 1(AJM3/23), 2(GHP-TM-III-07w), and 3(GHP-KB-06) inhibited cell growth with 3being the most potent in C1A (GI50 18.0 nM), C2H (GI50 17.0 nM), and LNCaP (GI50 17.9 nM) cells. In comparison to a standard cytotoxic agent such as doxorubicin (GI50 45.3 nM), 3(GI50 17.9 nM) inhibited LNCaP cell growth more potently. TDs induced G0/G1cell cycle arrest in LNCaP cells and decreased cells in the S phase. These changes correlated with modulation of G1phase cell cycle proteins including decreased cyclin D1, cyclin E, and cdk2 and increased p21waf1and p27Kip1. TDs also promoted apoptosis in LNCaP cells with increased expression of proapoptotic bax. These results demonstrate that TDs are potentially useful agents that warrant further preclinical development for treatment of prostate cancer.